Oncotelic Therapeutics (OTLC) Stock Chart & Stock Price History $0.03 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Chart Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Oncotelic Therapeutics Stock Price Performance5 Day Performance+7.14%1 Month Performance+60.98%3 Month Performance+19.57%6 Month Performance-13.84%Year-To-Date Performance-13.73%1 Year Performance+10.00% Receive OTLC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oncotelic Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…All you have to do is claim your free ticket to the event now… OTLC Stock Chart for Saturday, November, 2, 2024 OTLC Chart by TradingView Oncotelic Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/01/2024$0.03$0.03+2.33%$0.03$0.0323,808 shs$13.41 million10/31/2024$0.03$0.03-5.15%$0.03$0.0371,313 shs$13.10 million10/30/2024$0.04$0.03-6.85%$0.04$0.03271,765 shs$13.81 million10/29/2024$0.03$0.04+18.51%$0.04$0.03365,510 shs$14.83 million10/28/2024$0.04$0.03-12.00%$0.03$0.03325,998 shs$12.51 million10/25/2024$0.03$0.04+1.74%$0.04$0.04176,317 shs$14.22 million Get the Latest News and Ratings for OTLC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncotelic Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/24/2024$0.04$0.03-1.71%$0.04$0.0332,222 shs$13.98 million10/23/2024$0.04$0.04-4.11%$0.04$0.0361,000 shs$14.22 million10/22/2024$0.04$0.04+1.39%$0.04$0.04174,638 shs$14.83 million10/21/2024$0.04$0.04-2.70%$0.04$0.0420,030 shs$14.63 million10/18/2024$0.03$0.04+14.20%$0.04$0.03653,438 shs$15.03 million10/17/2024$0.03$0.03+17.60%$0.03$0.03536,500 shs$13.16 million10/16/2024$0.04$0.03-22.83%$0.04$0.03622,547 shs$11.19 million10/15/2024$0.03$0.04+19.00%$0.04$0.031.60 million shs$14.50 million10/14/2024$0.03$0.03+20.00%$0.03$0.031.33 million shs$12.19 million10/11/2024$0.02$0.03+23.76%$0.03$0.02743,576 shs$10.16 million10/10/2024$0.02$0.02-18.55%$0.02$0.02405,948 shs$8.21 million10/09/2024$0.03$0.02-4.62%$0.03$0.02331,857 shs$10.08 million10/08/2024$0.02$0.03+28.71%$0.03$0.021.03 million shs$10.56 million10/07/2024$0.02$0.02+15.43%$0.02$0.02418,275 shs$8.21 million10/04/2024$0.02$0.02-17.06%$0.02$0.021.75 million shs$7.11 million10/03/2024$0.02$0.02+2.93%$0.02$0.02138,585 shs$8.57 million10/02/2024$0.02$0.02-2.19%$0.02$0.0222,656 shs$8.33 million09/30/2024$0.02$0.02+3.45%$0.02$0.0218,801 shs$8.53 million09/27/2024$0.02$0.02-8.97%$0.02$0.02776,709 shs$8.25 million09/26/2024$0.02$0.02-2.19%$0.02$0.02235,526 shs$9.06 million09/25/2024$0.02$0.02-2.15%$0.02$0.02204,000 shs$9.26 million09/24/2024$0.02$0.02+4.48%$0.02$0.02571,942 shs$9.47 million09/23/2024$0.02$0.02-7.08%$0.02$0.02400,333 shs$9.06 million09/20/2024$0.02$0.02+2.13%$0.02$0.02178,403 shs$9.75 million09/19/2024$0.02$0.02+2.17%$0.02$0.02838,696 shs$9.55 million09/18/2024$0.02$0.02+5.99%$0.02$0.02137,054 shs$9.34 million09/17/2024$0.02$0.02-2.25%$0.02$0.02128,363 shs$8.82 million09/16/2024$0.02$0.02+4.72%$0.02$0.02273,484 shs$9.02 million09/13/2024$0.02$0.02$0.02$0.02241,085 shs$8.61 million09/12/2024$0.02$0.02-7.83%$0.02$0.0247,000 shs$8.61 million09/11/2024$0.02$0.02-3.36%$0.02$0.0245,700 shs$9.34 million09/10/2024$0.02$0.02+3.48%$0.02$0.02545,251 shs$9.67 million09/09/2024$0.02$0.02+0.88%$0.02$0.02195,244 shs$9.34 million09/06/2024$0.02$0.02+0.88%$0.02$0.0268,456 shs$9.26 millionWe recommended Nvidia in 2016, now we’re recommending this… (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry.09/05/2024$0.02$0.02+0.44%$0.02$0.02102,804 shs$9.18 million09/04/2024$0.02$0.02$0.02$0.02675,409 shs$9.14 million09/03/2024$0.02$0.02-0.88%$0.02$0.0292,926 shs$9.14 million09/02/2024$0.02$0.02$0.02$0.02153,300 shs$9.22 million08/30/2024$0.02$0.02+3.18%$0.02$0.02153,393 shs$9.22 million08/29/2024$0.02$0.02$0.02$0.02178,724 shs$8.94 million08/28/2024$0.02$0.02+7.32%$0.02$0.02158,500 shs$8.94 million08/27/2024$0.02$0.02-0.49%$0.02$0.023,005 shs$8.33 million08/26/2024$0.02$0.02-0.48%$0.02$0.0210,555 shs$8.37 million08/23/2024$0.02$0.02+0.98%$0.02$0.021.36 million shs$8.41 million08/22/2024$0.02$0.02-2.84%$0.02$0.0246,538 shs$8.33 million08/21/2024$0.02$0.02-1.86%$0.02$0.023,511 shs$8.57 million08/20/2024$0.02$0.02+2.87%$0.02$0.0216,502 shs$8.74 million08/19/2024$0.02$0.02-9.13%$0.02$0.02252,024 shs$8.49 million08/16/2024$0.02$0.02+11.65%$0.02$0.0297,861 shs$9.34 million08/15/2024$0.02$0.02-0.48%$0.02$0.0224,562 shs$8.37 million08/14/2024$0.02$0.02-3.72%$0.02$0.02563,562 shs$8.41 million08/13/2024$0.02$0.02-7.73%$0.02$0.021,199 shs$8.74 million08/12/2024$0.02$0.02+1.30%$0.02$0.022,525 shs$9.47 million08/09/2024$0.03$0.02-8.00%$0.02$0.0248,001 shs$9.34 million08/08/2024$0.02$0.03+13.64%$0.03$0.02308,502 shs$10.16 million08/07/2024$0.02$0.02+4.76%$0.02$0.0213,000 shs$8.94 million08/06/2024$0.03$0.02-19.23%$0.03$0.02289,076 shs$8.53 million08/05/2024$0.03$0.03-5.80%$0.03$0.0354,773 shs$10.56 million08/02/2024$0.03$0.03$0.03$0.031,000 shs$11.21 million08/01/2024$0.03$0.03-1.43%$0.03$0.03500 shs$11.21 million Related Companies KRON Stock Price Chart DTIL Stock Price Chart IMRX Stock Price Chart CVM Stock Price Chart PHGE Stock Price Chart BRNS Stock Price Chart MNPR Stock Price Chart THTX Stock Price Chart ATNM Stock Price Chart VNRX Stock Price Chart Receive OTLC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oncotelic Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:OTLC) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncotelic Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncotelic Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
